ArticleOncology reports2022

[Corrigendum] MicroRNA‑218 inhibits tumor angiogenesis of human renal cell carcinoma by targeting GAB2.

Lijun Mu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.